LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 16 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANTA MONICA PARTNERS LP | 166,667 | $124,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 99,644 | $74,000 | 0.05% |
| Almanack Investment Partners, LLC. | 248,084 | $185,000 | 0.02% |
| Warberg Asset Management LLC | 14,500 | $11,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 16,948 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 49 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 25,794 | $19,000 | 0.00% |
| STATE STREET CORP | 35,956 | $28,000 | 0.00% |
| MORGAN STANLEY | 71,054 | $53,000 | 0.00% |
| Citadel Advisors | 30,063 | $23,000 | 0.00% |